These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 1421905)

  • 1. Atrial natriuretic peptide in the diagnosis of patent ductus arteriosus.
    Weir FJ; Smith A; Littleton P; Carter N; Hamilton PA
    Acta Paediatr; 1992 Sep; 81(9):672-5. PubMed ID: 1421905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide and patent ductus arteriosus in preterm infants.
    Rascher W; Seyberth HW
    Arch Dis Child; 1987 Nov; 62(11):1165-7. PubMed ID: 2961310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants.
    Nuntnarumit P; Chongkongkiat P; Khositseth A
    Acta Paediatr; 2011 Sep; 100(9):1217-21. PubMed ID: 21457304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome.
    Kääpä P; Lanning P; Koivisto M
    Acta Paediatr Scand; 1983 Mar; 72(2):179-84. PubMed ID: 6340412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular biomarkers pro-atrial natriuretic peptide and pro-endothelin-1 to monitor ductus arteriosus evolution in very preterm infants.
    Grass B; Baumann P; Arlettaz R; Fouzas S; Meyer P; Spanaus K; Wellmann S
    Early Hum Dev; 2014 Jun; 90(6):293-8. PubMed ID: 24661445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants.
    König K; Guy KJ; Drew SM; Barfield CP
    Acta Paediatr; 2015 Apr; 104(4):e139-42. PubMed ID: 25488470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late closure of the ductus arteriosus using indomethacin in the preterm infant.
    Kresch MJ; Moya FR; Ascuitto RJ; Ross-Ascuitto NT; Heusser F
    Clin Pediatr (Phila); 1988 Mar; 27(3):140-3. PubMed ID: 3342597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus.
    Keller RL; Clyman RI
    Pediatrics; 2003 Sep; 112(3 Pt 1):583-7. PubMed ID: 12949288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants.
    Puddy VF; Amirmansour C; Williams AF; Singer DR
    Clin Sci (Lond); 2002 Jul; 103(1):75-7. PubMed ID: 12095406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].
    Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D
    Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide in patent ductus arteriosus.
    Andersson S; Tikkanen I; Pesonen E; Meretoja O; Hynynen M; Fyhrquist F
    Pediatr Res; 1987 Apr; 21(4):396-8. PubMed ID: 2952937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants.
    Choi BM; Lee KH; Eun BL; Yoo KH; Hong YS; Son CS; Lee JW
    Pediatrics; 2005 Mar; 115(3):e255-61. PubMed ID: 15687418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiographic and echocardiographic evaluation of newborns treated with indomethacin for patent ductus arteriosus.
    Edwards DK; Higgins CB; Merritt TA; DiSessa TG; Friedman WF
    AJR Am J Roentgenol; 1978 Dec; 131(6):1009-13. PubMed ID: 104563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined noninvasive assessment of the patent ductus arteriosus in the preterm infant before and after indomethacin treatment.
    Smallhorn JF; Gow R; Olley PM; Freedom RM; Swyer PR; Perlman M; Rowe RD
    Am J Cardiol; 1984 Dec; 54(10):1300-4. PubMed ID: 6507302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin therapy of patent ductus in preterm infants controlled by plasma levels.
    Lewis IG; Harvey DP; Maxwell GM
    Aust Paediatr J; 1985 Aug; 21(3):181-3. PubMed ID: 4062716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study.
    Dollberg S; Lusky A; Reichman B
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):184-8. PubMed ID: 15699694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.